Literature DB >> 7787756

Establishment and characterization of a new Ph1-positive chronic myeloid leukemia cell line MC3 with trilineage phenotype and an altered p53 gene.

M Okabe1, Y Kunieda, S Nakane, M Kurosawa, T Itaya, W R Vogler, M Shoji, T Miyazaki.   

Abstract

A new Ph1-positive leukemic cell line (MC3) expressing the P210bcr/abl oncoprotein was established from a patient with CML in blast crisis. The MC3 cells showed the trilineage phenotype of myeloid, lymphoid (CD19) and megakaryocytoid lineages, and had a proliferative response to rhIL-1 and rhIL-3 in the serum-free culture. These results and the expression of CD34 indicated that the MC3 cells have characteristics of hematopoietic progenitor cells. Recently, it has been documented that alterations of the p53 gene in leukemic cells are frequently detected during the blast crisis of CML. The MC3 cells contained the altered p53 gene. In addition, the original leukemic cells showed the point-mutational activation of the N-ras gene and an additional chromosomal abnormality inv(3q), but the MC3 cells contained no such abnormalities, indicating that not all of the original leukemic cells had these abnormalities. Thus, the MC3 cell line may provide several insights into investigations of the blast crisis in CML as well as hematopoietic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787756     DOI: 10.3109/10428199509054439

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Transcriptional regulation of the SCL locus: identification of an enhancer that targets the primitive erythroid lineage in vivo.

Authors:  E Delabesse; S Ogilvy; M A Chapman; S G Piltz; B Gottgens; A R Green
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

2.  Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells.

Authors:  M Kurosawa; M Okabe; N Hara; K Kawamura; S Suzuki; K Sakurada; M Asaka
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

3.  Gads (Grb2-related adaptor downstream of Shc) is required for BCR-ABL-mediated lymphoid leukemia.

Authors:  L C Gillis; D M Berry; M D Minden; C J McGlade; D L Barber
Journal:  Leukemia       Date:  2013-02-12       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.